Brown Brothers Harriman & Co’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.7K | Hold |
40
| – | – | ﹤0.01% | 1277 |
|
|
2026
Q1 | $23.7K | Hold |
40
| – | – | ﹤0.01% | 1200 |
|
|
2025
Q4 | $19.5K | Buy |
40
+10
| +33% | +$4.66K | ﹤0.01% | 1212 |
|
|
2025
Q3 | $12.6K | Hold |
30
| – | – | ﹤0.01% | 1253 |
|
|
2025
Q2 | $8.62K | Buy |
30
+7
| +30% | +$2.09K | ﹤0.01% | 1215 |
|
|
2025
Q1 | $7.09K | Hold |
23
| – | – | ﹤0.01% | 1112 |
|
|
2024
Q4 | $8.12K | Hold |
23
| – | – | ﹤0.01% | 1156 |
|
|
2024
Q3 | $8.24K | Hold |
23
| – | – | ﹤0.01% | 1084 |
|
|
2024
Q2 | $7.33K | Hold |
23
| – | – | ﹤0.01% | 1000 |
|
|
2024
Q1 | $5.28K | Hold |
23
| – | – | ﹤0.01% | 1038 |
|
|
2023
Q4 | $5.06K | Hold |
23
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q3 | $5.2K | Hold |
23
| – | – | ﹤0.01% | 1020 |
|
|
2023
Q2 | $5.08K | Hold |
23
| – | – | ﹤0.01% | 1050 |
|
|
2023
Q1 | $5.15K | Buy |
+23
| New | +$5.67K | ﹤0.01% | 1059 |
|
|
2019
Q2 | – | Sell |
-160
| Closed | -$19K | – | 1229 |
|
|
2019
Q1 | $19K | Hold |
160
| – | – | ﹤0.01% | 739 |
|
|
2018
Q4 | $17K | Hold |
160
| – | – | ﹤0.01% | 644 |
|
|
2018
Q3 | $20K | Hold |
160
| – | – | ﹤0.01% | 618 |
|
|
2018
Q2 | $18K | Hold |
160
| – | – | ﹤0.01% | 604 |
|
|
2018
Q1 | $18K | Sell |
160
-30
| -16% | -$3.81K | ﹤0.01% | 595 |
|
|
2017
Q4 | $28K | Buy |
190
+30
| +19% | +$3.81K | ﹤0.01% | 590 |
|
|
2017
Q3 | $19K | Hold |
160
| – | – | ﹤0.01% | 603 |
|
|
2017
Q2 | $21K | Hold |
160
| – | – | ﹤0.01% | 589 |
|
|
2017
Q1 | $22K | Sell |
160
-281
| -64% | -$42.6K | ﹤0.01% | 581 |
|
|
2016
Q4 | $63K | Hold |
441
| – | – | ﹤0.01% | 460 |
|
|
2016
Q3 | $52K | Hold |
441
| – | – | ﹤0.01% | 439 |
|
|
2016
Q2 | $47K | Buy |
441
+36
| +9% | +$4.02K | ﹤0.01% | 459 |
|
|
2016
Q1 | $45K | Hold |
405
| – | – | ﹤0.01% | 452 |
|
|
2015
Q4 | $63K | Hold |
405
| – | – | ﹤0.01% | 437 |
|
|
2015
Q3 | $53K | Hold |
405
| – | – | ﹤0.01% | 485 |
|
|
2015
Q2 | $70K | Hold |
405
| – | – | ﹤0.01% | 472 |
|
|
2015
Q1 | $70K | Hold |
405
| – | – | ﹤0.01% | 461 |
|
|
2014
Q4 | $52K | Hold |
405
| – | – | ﹤0.01% | 513 |
|
|
2014
Q3 | $52K | Hold |
405
| – | – | ﹤0.01% | 514 |
|
|
2014
Q2 | $36K | Hold |
405
| – | – | ﹤0.01% | 552 |
|
|
2014
Q1 | $38K | Sell |
405
-405
| -50% | -$41.4K | ﹤0.01% | 534 |
|
|
2013
Q4 | $92K | Buy |
+810
| New | +$73K | ﹤0.01% | 476 |
|
Other funds holding UTHR
ACA
JT
Brown Brothers Harriman & Co's UTHR Position: Q2 2026 in Review
Brown Brothers Harriman & Co held its United Therapeutics (UTHR) position steady in Q2 2026 at 40 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1277.
Brown Brothers Harriman & Co first reported a position in UTHR in Q4 2013 and has held it in 36 quarters since. The position peaked at $92K in Q4 2013. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Brown Brothers Harriman & Co held 40 shares of United Therapeutics worth $21.7K as of Q2 2026.
- Brown Brothers Harriman & Co left its United Therapeutics share count unchanged in Q2 2026.
- United Therapeutics made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1277 holding.
- Brown Brothers Harriman & Co first reported a position in United Therapeutics in Q4 2013 and has held it in 36 quarters since.
- Brown Brothers Harriman & Co's United Therapeutics position peaked at $92K in Q4 2013.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.